Skip to main content Skip to navigation

Genome-Scale Functional Mapping of Immune Disease Variants with CRISPR and Single-cell RNA-seq

Watch On-Demand

Combining CRISPR and single-cell RNA-seq


Genome-wide association studies have uncovered thousands of immune disease-associated variants, yet most lie in non-coding regions, making it difficult to identify their target genes and mechanisms of action.

 

In this webinar, Dewi Moonen and Daniel Schraivogel of the European Molecular Biology Laboratory will discuss an experimental framework to link disease-associated variants to cis-regulatory elements and their downstream gene effects in primary human CD4+ T cells at scale.

 

Using CRISPR interference, coupled with targeted single-cell RNA sequencing with the BD Rhapsody™ HT Xpress System, the EMBL team systematically perturbed more than one thousand regulatory elements overlapping immune disease risk variants and directly measured their impact on candidate target genes and regulatory networks. By integrating causal perturbation data with chromatin, genetic, and regulatory network information, they uncovered functional regulatory interactions in a disease-relevant immune cell type.

 

Webinar attendees will learn how perturbation-based approaches can resolve variant-to-gene relationships, how regulatory elements can be functionally characterized at scale in primary cells, and how these data advance the interpretation of immune disease genetics.

 

Our speakers will also share best practices for performing large-scale CRISPR screens with single-cell RNA-sequencing and the BD Rhapsody™ System in a challenging primary cell type.

 

Speakers

 

Dewi Moonen, PhD

European Molecular Biology Laboratory (EMBL)

Genome Biology Unit, Heidelberg, Germany


Dewi Moonen completed her PhD in the Steinmetz lab at the European Molecular Biology Laboratory. Before joining the Steinmetz lab, she obtained two simultaneous master’s degrees in the Netherlands — one in Life Science and Technology at Leiden University and the other focused on using the cell as a factory at Delft University of Technology. During her master's, she worked on yeast vitamin prototrophy at TU Delft’s Industrial Microbiology department and developed CRISPR editing tools for mouse embryos in Lin He’s lab at UC Berkeley. Dr. Moonen then worked in Thijn Brummelkamp’s group at the Netherlands Cancer Institute, utilizing haplogenetic CRISPR screening, before starting her doctoral research in functional genomics, using large-scale CRISPR screens to elucidate T-cell function.

  

Daniel Schraivogel, PhD

European Molecular Biology Laboratory (EMBL)

Genome Biology Unit, Heidelberg, Germany

 

Daniel Schraivogel is a visiting scientist in the laboratory of Prof. Dr. Lars Steinmetz at the European Molecular Biology Laboratory (EMBL). He pioneers novel functional genomics methods that integrate CRISPR/Cas9 genetic screening and single-cell multimodal readouts. He uses these technologies to map the function of genes, regulatory elements, and disease-associated variants and to identify disease mechanisms and drug targets. Prior to joining EMBL, Dr. Schraivogel completed his PhD in the laboratory of Prof. Dr. Gunter Meister at the Max-Planck-Institute (MPI) of Biochemistry in Munich and Regensburg University, studying the function of short non-coding RNAs and their associated proteins in health and disease.

Access the On-Demand Webinar


*Required fields

   

   

For Research Use Only. Not for use in diagnostic or therapeutic procedures.